SCHEMBL5758176

SCHEMBL5758176

c1ccc2cc(-c3cnc(Cc4ccc5c(c4)OCO5)[nH]3)ccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.53
FAAH O00519 1/20 0.44
ADORA2A P29274 1/20 0.43
FGFR1 P11362 1/20 0.41
FGFR2 P21802 1/20 0.41
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 3/20 0.41
HPGDS O60760 2/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5757421 0.83 NPC1 (0.47) PDE10AADORA2AKDM4EALDH1A1LMNA
SCHEMBL5756342 0.83 ADORA2A (0.56) PDE10AADORA2AKDM4EMAPTL3MBTL1
SCHEMBL5759979 0.79 NPY5R (0.51) ADORA2AHPGDSPYGL
SCHEMBL5758399 0.75 SCN2A (0.47) FGFR2HPGDSMAPTMAPK1HTT
SCHEMBL5757793 0.73 ALDH1A1 (0.45) ADORA2AKDM4EALDH1A1LMNAMAPT
SCHEMBL8666612 0.69 MEN1 (0.64) KDM4EALDH1A1LMNAMAPTNPC1
SCHEMBL10057822 0.68 DCUN1D1 (0.51) PDE10AKDM4EALDH1A1MAPTHPGD
SCHEMBL9036923 0.67 PTGS2 (0.51) FAAHALDH1A1MAPTHPGDMEN1
SCHEMBL7479626 0.66 ALDH1A1 (0.47) ADORA2AALDH1A1LMNAMAPTNPC1
SCHEMBL22505295 0.66 NLN (0.46) PDE10APYGL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1194144-B1 ANTIBACTERIAL COMPOUNDS AFFINIUM PHARM INC (CA) 2006-11-02 EP claimed
US-20030149089-A1 Antibacterial compounds SMITHKLINE BEECHAM CORPORATION 2003-08-07 US claimed
EP-1194144-B1 ANTIBACTERIAL COMPOUNDS AFFINIUM PHARM INC (CA) 2006-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149089-A1 Antibacterial compounds MRPL21, MRPS28, SPOUT1 PDE10A 2803/4885FAAH 3587/4885ADORA2A 3924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.